Incanthera (AQSE:INC) Price-to-Tangible-Book : (As of Jun. 22, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Incanthera Price-to-Tangible-Book?

As of today (2024-06-22), Incanthera's share price is £0.245. Incanthera's Tangible Book per Share of Sep. 2023 for the quarter that ended in Sep. 2023 was £-0.01. Hence, Incanthera's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Incanthera's Price-to-Tangible-Book or its related term are showing as below:

During the past 4 years, Incanthera's highest Price to Tangible Book Ratio was 17.63. The lowest was 9.21. And the median was 15.70.

AQSE:INC's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.6
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Incanthera's share price is £0.245. Incanthera's Book Value per Sharefor the quarter that ended in Sep. 2023 was £-0.01. Hence, Incanthera's P/B Ratio of today is .

Incanthera Price-to-Tangible-Book Historical Data

The historical data trend for Incanthera's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incanthera Price-to-Tangible-Book Chart

Incanthera Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Price-to-Tangible-Book

15.71

9.21

17.63

Incanthera Semi-Annual Data
	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Price-to-Tangible-Book	Get a 7-Day Free Trial			15.69	17.63	-	-	-

Competitive Comparison of Incanthera's Price-to-Tangible-Book

For the Biotechnology subindustry, Incanthera's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Incanthera's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Incanthera's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Incanthera's Price-to-Tangible-Book falls into.

Incanthera Price-to-Tangible-Book Calculation

Incanthera's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Sep. 2023 )
	=	0.245	/	-0.009
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Incanthera Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Incanthera's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Incanthera (AQSE:INC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

76 King Street, Manchester, GBR, M2 4NH

Website

http://www.incanthera.com

Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops solutions to current clinical, commercially relevant unmet needs, utilising a new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.

Incanthera (AQSE:INC) Headlines

No Headlines